Citation Impact
Citing Papers
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
1990 StandoutNature
Ocular Hypotensive Effects of an Intratracheally Delivered Liposomal Δ9-Tetrahydrocannabinol Preparation in Rats
2006
Inadequate Antimicrobial Treatment of Infections
1999 Standout
Validation of a new quality of life questionnaire for benign prostatic hyperplasia
1992
Heart-Rate Profile during Exercise as a Predictor of Sudden Death
2005 Standout
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
2001 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Blinding in randomised trials: hiding who got what
2002
Adverse Health Effects of Marijuana Use
2014 Standout
Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis
2003 Standout
Vascularized and functional human liver from an iPSC-derived organ bud transplant
2013 StandoutNature
Clinical trials of arrhythmia management: Methods or madness
1996
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
A Randomized Trial of the Efficacy and Tolerability of the COX-2 Inhibitor Rofecoxib vs Ibuprofen in Patients With Osteoarthritis
2000
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Rating Health Information on the Internet
1998 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU Setting
2000 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
Severe Sepsis and Septic Shock
2013 Standout
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
1996 Standout
The Impact of Nosocomial Infections on Patient Outcomes Following Cardiac Surgery
1997
Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction
1997
Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?
1998
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
2010 Standout
The central neuropharmcology of psychotropic cannabinoids
1988
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
1999 Standout
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Sepsis and septic shock
2018 Standout
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
1996
SEVERITY OF ILLNESS: CONCEPTS AND MEASUREMENTS
1987 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
1997
Δ9-Tetrahydrocannbinol Accounts for the Antinociceptive, Hypothermic, and Cataleptic Effects of Marijuana in Mice
2005
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
1997 Standout
Adjunctive Drug Therapy of Acute Myocardial Infarction — Evidence from Clinical Trials
1996
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Value of Programmed Ventricular Stimulation in Patients with Congenital Heart Disease
1999
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Interventions to Enhance Patient Adherence to Medication Prescriptions
2002 Standout
Sympathetic activation, ventricular repolarization and Ikrblockade: Implications for the antifibrillatory efficacy of potassium channel blocking agents
1995
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
1995
Mortality in the Survival With ORal D-Sotalol (SWORD) Trial: Why Did Patients Die? 11This work was supported by a grant from Bristol-Myers Squibb, Princeton, New Jersey.
1998
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Psychological reactions to chronic illness-related disability as a function of its severity and type
1981
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Patient compliance and the conduct and interpretation of therapeutic trials
1987
Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana
1987
Depression and Coronary Heart Disease
2008 Standout
The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.
1998 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
“Proving the null hypothesis” in clinical trials
1982
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Sudden Cardiac Death
1998 Standout
Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men
2005
Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration
1980
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
1992 StandoutScience
Cannabinoids for Medical Use
2015 Standout
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Analgesic Effect of Delta‐9‐Tetrahydrocannabinol
1975
Repeat Administration of Marihuana Smoke to Humans
1974
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
2008
Interim Analyses: The Repeated Confidence Interval Approach
1989
Effect of Marihuana on Intraocular and Blood Pressure in Glaucoma
1980
Works of Bruce E. Rodda being referenced
Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial)
1995
Clinical trials: Design, conduct, and analysis
1987
Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effects
1976
Physiological Disposition of Fenoprofen in Man I: Pharmacokinetic Comparison of Calcium and Sodium Salts Administered Orally
1971
Propranolol antagonism of marihuana induced tachycardia
1972
Comparative Pharmacology of Δ9-Tetrahydrocannabinol and its Metabolite, 11-OH-Δ9-Tetrahydrocannabinol
1973
Dose‐response analysis of the efJects of tetrahydrocannabinol in man
1971
Prediction of anxiety and depression patterns among coronary patients using a markov process analysis
1971
Determining the probability of an important difference in bioavailability
1980